An observational study in Obsessive-compulsive Disorder, sponsored by Susanne Walitza. Recruiting at 1 site in Switzerland. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-05-13.
Sponsored by Susanne Walitza · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal variables/predictors can be recognized, understood and taken carefully into account. The anticipated incremental knowledge will ultimately help children and young people with obsessive-compulsive disorders to receive faster and more effective treatment.
637 studies on the registry are indexed under Obsessive-Compulsive Disorder; 167 are open to participants now.
This study's planned enrollment of 625 is above the median of 133 across 86 observational studies indexed under Obsessive-Compulsive Disorder.
Browse Obsessive-Compulsive Disorder studies →Susanne Walitza is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The sample consist of pupils with obsessive-compulsive disorder 4 to 18 years
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Symptoms severity of obsessive and compulsive symptoms in children and adolescents
The clinician report questionnaire (BY-BOCS) contains 19 items designed to assess severity of obsessive and compulsive symptoms in children and adolescents.The test uses a four point scale to rate the severity of their obsessive compulsive behaviors. Higher score means a worse outcome.
Time frame: 24 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started May 2020 (actual). Primary completion is estimated for Mar 2026, 70 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Obsessive-Compulsive Disorder →
Susanne Walitza